HB516
Prescription drugs; labels provided for blind and disabled users.
Status:
Enacted
Latest Action:
April 8, 2024
Governor: Approved by Governor-Chapter 725 (effective 7/1/24)
Chief Patron:
Patrick Hope (D)
Session:
2024 Regular Session
Summary
As Passed Both Chambers. Prescription drugs; labels; blind and disabled users.
Requires pharmacies to notify each person who identifies themselves or a patient as blind, visually impaired, or otherwise print disabled to whom a prescription drug is dispensed that an accessible prescription label or alternate accommodation is available to the person upon request at no additional cost. The bill requires the ... (More) Board of Pharmacy to promulgate regulations implementing the provisions of the bill no later than December 31, 2024. (Less)-
Bill History
- 01/08/2024 - House: Prefiled and ordered printed; offered 01/10/24 24104715D
- 01/08/2024 - House: Referred to Committee on Health and Human Services
- 01/17/2024 - House: Assigned sub: Health
- 01/17/2024 - House: Impact statement from DPB (HB516)
- 02/06/2024 - House: Subcommittee recommends reporting (5-Y 2-N)
- 02/08/2024 - House: Reported from Health and Human Services (17-Y 5-N)
- 02/11/2024 - House: Read first time
- 02/12/2024 - House: Read second time and engrossed
- 02/13/2024 - House: Read third time and passed House (61-Y 37-N)
- 02/13/2024 - House: VOTE: Passage (61-Y 37-N) Close Floor Vote
- 02/14/2024 - Senate: Constitutional reading dispensed
- 02/14/2024 - Senate: Referred to Committee on Education and Health
- 02/21/2024 - Senate: Assigned Education and Health Sub: Health Professions
- 02/23/2024 - Senate: Senate subcommittee amendments and substitutes offered
- 02/29/2024 - Senate: Senate committee, floor amendments and substitutes offered
- 02/29/2024 - Senate: Reported from Education and Health with substitute (13-Y 0-N 2-A)
- 02/29/2024 - Senate: Committee substitute printed 24108563D-S1
- 03/01/2024 - Senate: Constitutional reading dispensed (40-Y 0-N)
- 03/04/2024 - House: Impact statement from DPB (HB516S1)
- 03/04/2024 - Senate: Read third time
- 03/04/2024 - Senate: Reading of substitute waived
- 03/04/2024 - Senate: Committee substitute agreed to 24108563D-S1
- 03/04/2024 - Senate: Engrossed by Senate - committee substitute HB516S1
- 03/04/2024 - Senate: Passed Senate with substitute (39-Y 0-N)
- 03/05/2024 - House: Senate substitute agreed to by House 24108563D-S1 (74-Y 26-N)
- 03/05/2024 - House: VOTE: Adoption (74-Y 26-N)
- 03/25/2024 - House: Enrolled
- 03/25/2024 - House: Bill text as passed House and Senate (HB516ER)
- 03/25/2024 - Senate: Signed by President
- 03/26/2024 - House: Signed by Speaker
- 03/27/2024 - House: Impact statement from DPB (HB516ER)
- 03/27/2024 - House: Enrolled Bill communicated to Governor on March 27, 2024
- 03/27/2024 - Governor: Governor's Action Deadline 11:59 p.m., April 8, 2024
- 04/08/2024 - Governor: Approved by Governor-Chapter 725 (effective 7/1/24)
